Immune-Pineal Axis Function in Chronic Tension-Type Headache
Immune-Pineal Axis Function in Chronic Tension-Type Headache: Noradrenergic Modulation and the Effect of Electroacupuncture
Studienübersicht
Status
Bedingungen
Intervention / Behandlung
Detaillierte Beschreibung
Tension-type headache can be defined as a constant sensation of pressure or heaviness, and is a highly-prevalent condition in the health services. The objective of the present study is to investigate the function of the immuno-pineal axis in chronic tension headache, focussed on the neuro-immune regulatory dysfunction. In addition, the effect of neuro-stimulation (electroacupuncture) on the function of this axis will also be studied.
This is a clinical Trial study, randomised, in parallel, cross-over with a blinded assessor, and with a sham placebo control.
The study will be carried out in the Clinical Research Outpatient Clinic of the Hospital de Clínicas de Porto Alegre (HCPA), with women aged between 18 and 60 years old. The participants will respond to questionnaires at the beginning and end of each therapeutic intervention, with 24-hour urine, blood and saliva collection. The therapeutic intervention will include: 10 electroacupuncture sessions and 10 sham placebo sessions. The measurements taken will be: quality of life, depression, impact of headache on daily life, sleep quality, chronotropic types, immuno-inflammatory mediators, levels of 6-sulfatoxymelatonin, and salivary cortisol.
Through these interventions it is hoped that patients will present an improvement in their pain presentation, quality of life and sleep, as well as central autonomic regulation. Evidence for these hypotheses will support a minimally-invasive treatment, with few side-effects and a low cost.
Studientyp
Einschreibung (Tatsächlich)
Phase
- Phase 2
- Phase 3
Kontakte und Standorte
Studienorte
-
-
Rio Grande do Sul
-
Porto Alegre, Rio Grande do Sul, Brasilien, 90035-003
- Hospital de Clinicas e Porto Alegre (HCPA)
-
-
Teilnahmekriterien
Zulassungskriterien
Studienberechtigtes Alter
Akzeptiert gesunde Freiwillige
Studienberechtigte Geschlechter
Beschreibung
Inclusion Criteria:
- Women,
- Aged between 18 and 60 years old,
- Providing informed consent to participate in the study,
- Literate,
- Clinical diagnosis of Chronic Tension-Type Headache according to the International Headache Society.
Exclusion Criteria:
- Psychiatric or neurologic disorder that unable patient to consent and follow study protocol,
- De-compensated systemic disease,
- Chronic inflammatory disease (e.g. Systemic Lupus Erythematous, Rheumatoid Arthritis),
- HIV.
Studienplan
Wie ist die Studie aufgebaut?
Designdetails
- Hauptzweck: Behandlung
- Zuteilung: Zufällig
- Interventionsmodell: Crossover-Aufgabe
- Maskierung: Single
Waffen und Interventionen
Teilnehmergruppe / Arm |
Intervention / Behandlung |
|---|---|
|
Experimental: Electroacupuncture
All patients will receive 10 electroacupuncture sessions.
|
Eletroacupuncture performed using acupuncture needles.
Andere Namen:
|
|
Schein-Komparator: Placebo Sham
All patients will receive 10 placebo sham sessions.
|
Placebo Sham is performed using electrodes, without electrical stimulation.
Lights and sounds were identical to active treatment.
Andere Namen:
|
Was misst die Studie?
Primäre Ergebnismessungen
Ergebnis Maßnahme |
Maßnahmenbeschreibung |
Zeitfenster |
|---|---|---|
|
Pain Visual Analogue Scale (VAS)
Zeitfenster: An expected average of 3 months. (At baseline and at the end of each intervention period).
|
The intensity of pain was measured by a 10 cm VAS.
The scores range from no pain (zero) to the worst possible pain (10 cm).
|
An expected average of 3 months. (At baseline and at the end of each intervention period).
|
Sekundäre Ergebnismessungen
Ergebnis Maßnahme |
Maßnahmenbeschreibung |
Zeitfenster |
|---|---|---|
|
Headache Impact Test (HIT-6)
Zeitfenster: An expected average of 3 months. (At baseline and at the end of each intervention period).
|
This test was developed in 2004, and has equivalent psychometric properties in nine languages, including Portuguese.
It consists of six questions that assess the impact of headache on the ability to work, study, home and in social situations.
|
An expected average of 3 months. (At baseline and at the end of each intervention period).
|
Andere Ergebnismessungen
Ergebnis Maßnahme |
Maßnahmenbeschreibung |
Zeitfenster |
|---|---|---|
|
Biomarkers (BDNF nd TNF)
Zeitfenster: An expected average of 3 months. (At baseline and at the end of each intervention period).
|
The BDNF and the TNF will be measured by ELISA.
|
An expected average of 3 months. (At baseline and at the end of each intervention period).
|
Mitarbeiter und Ermittler
Mitarbeiter
Ermittler
- Studienstuhl: Wolnei Caumo, MD, PhD, Hospital de Clinicas de Porto Alegre
- Hauptermittler: Mônica Chassot, Federal University of Health Science of Porto Alegre
- Hauptermittler: Francislea C. Sehn, Federal University of Health Science of Porto Alegre
- Hauptermittler: Rafael Vercelino, Federal University of Health Science of Porto Alegre
Studienaufzeichnungsdaten
Haupttermine studieren
Studienbeginn
Primärer Abschluss (Tatsächlich)
Studienabschluss (Tatsächlich)
Studienanmeldedaten
Zuerst eingereicht
Zuerst eingereicht, das die QC-Kriterien erfüllt hat
Zuerst gepostet (Schätzen)
Studienaufzeichnungsaktualisierungen
Letztes Update gepostet (Schätzen)
Letztes eingereichtes Update, das die QC-Kriterien erfüllt
Zuletzt verifiziert
Mehr Informationen
Begriffe im Zusammenhang mit dieser Studie
Schlüsselwörter
Zusätzliche relevante MeSH-Bedingungen
Andere Studien-ID-Nummern
- 09-259
Diese Informationen wurden ohne Änderungen direkt von der Website clinicaltrials.gov abgerufen. Wenn Sie Ihre Studiendaten ändern, entfernen oder aktualisieren möchten, wenden Sie sich bitte an register@clinicaltrials.gov. Sobald eine Änderung auf clinicaltrials.gov implementiert wird, wird diese automatisch auch auf unserer Website aktualisiert .